All PlansAdministrativeLow impact
Follow-Up Care for Children Prescribed ADHD Medication HEDIS measure (ADD)
Cigna·Pediatrics, Family Medicine, Psychiatry·Pharmacy
We identified it
Jun 19, 2026
Summary
This is an informational update about HEDIS quality measures for ADHD medication follow-up care in children ages 6-12. It provides performance data and best practice recommendations for prescribing providers to improve compliance with required follow-up visits within 30 days of initiation and during continuation phases.
Action Required
No immediate billing system changes required. Providers should review the recommended best practices for ADHD medication follow-up scheduling to improve HEDIS quality measure performance, including scheduling initial follow-up within 30 days and at least two additional visits over 9 months.